| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 16,895 | 17,801 | ||
| Receivables from atm sales | 0 | 0 | ||
| Other current assets | 113 | 116 | ||
| Prepaid expenses | 1,796 | 1,357 | ||
| Tax credit receivable | 1,662 | 1,609 | ||
| Total current assets | 20,466 | 20,883 | ||
| Property, plant and equipment, net | 330 | 322 | ||
| Total assets | 20,796 | 21,205 | ||
| Accounts payable | 4,602 | 4,605 | ||
| Accrued expenses and other current liabilities | 2,712 | 2,977 | ||
| Warrant derivative liability | 0 | 0 | ||
| Income taxes payable | 81 | 81 | ||
| Convertible promissory notes and accrued interest, net of debt discount | 1,390 | 1,375 | ||
| Total current liabilities | 8,785 | 9,038 | ||
| Total liabilities | 8,785 | 9,038 | ||
| Common stock, 0.0001 par value (250,000,000 shares authorized) 18,712,224 and 7,302,797 shares issued and 16,111,461 and 7,302,797 outstanding at september 30, 2025, and december 31, 2024, respectively | 3 | 2 | ||
| Additional paid-in capital | 143,841 | 141,209 | ||
| Accumulated other comprehensive loss | -2,303 | -2,461 | ||
| Accumulated deficit | -126,824 | -124,018 | ||
| Treasury stock, at cost 2,600,763 shares | 2,706 | 2,565 | ||
| Total stockholders equity | 12,011 | 12,167 | ||
| Total liabilities and stockholders equity | 20,796 | 21,205 | ||
Allarity Therapeutics, Inc. (ALLR)
Allarity Therapeutics, Inc. (ALLR)